Glaucoma 360 Event Overview
The Glaucoma 360, hosted by the Glaucoma Research Foundation, is a prominent three-day event showcasing advancements in glaucoma research and patient care. Each year, this event brings together experts, researchers, and enthusiasts in the field to collaborate and exchange ideas. This year's festivities will include various segments, starting with a Gala, followed by an innovation incubator, and culminating in continuing medical education programs. The event is designed to elevate awareness and support research initiatives aimed at eradicating glaucoma and enhancing the lives of those affected.
Exciting Gala and Recognition
The Gala is set to be a highlight of the Glaucoma 360 event. It serves not only as a celebration but also as a fundraiser for the Glaucoma Research Foundation’s vital research projects and educational initiatives. Esteemed honored guests will include notable figures in the glaucoma research community. Dr. Sean Ianchulev will receive the prestigious Catalyst Award for his impactful contributions, alongside Dr. Michael Belkin who will receive the Visionary Award for his transformative innovations in glaucoma care. This year, the prestigious President’s Award will pay tribute to Delta Gamma, a dedicated organization supporting individuals with visual impairments.
New Horizons Forum
This year's New Horizons Forum promises an engaging platform for dialogue among industry leaders, clinicians, and patients. Scheduled for the second day of the event, it will draw nearly 400 participants, fostering collaboration and innovation. Attendees are encouraged to share insights and contribute to discussions that could lead to new therapies and advancements in glaucoma diagnostics.
Keynote Address
The event will feature an inspiring keynote address from Dr. Carla Siegfried, a leading glaucoma researcher from Washington University. Her presentation, titled "Glaucoma Racial Disparities: Applying Innovation from Bench to Clinic to Community," highlights the crucial issues surrounding equity in glaucoma treatment and research.
Artificial Intelligence in Glaucoma Management
As technology progresses, artificial intelligence is becoming a pivotal tool in transforming glaucoma diagnosis and therapy. A session led by Dr. Felipe A. Medeiros and Dr. Inder Paul Singh will delve into the revolutionary applications of AI in managing this complex disease, thus providing medical professionals with valuable insights into the future of glaucoma care.
Continuing Medical Education
The final day of the Glaucoma 360 event will feature two Continuing Medical Education symposia, targeting both ophthalmologists and optometrists. Medical professionals will benefit from the latest educational offerings, with a Keynote Lecture from Dr. M. Roy Wilson, enhancing their understanding and capabilities in glaucoma management.
Frequently Asked Questions
What is the Glaucoma 360 event?
The Glaucoma 360 is an annual event organized by the Glaucoma Research Foundation, consisting of a Gala, educational forums, and networking opportunities focused on glaucoma research and treatment.
When is this year's Glaucoma 360 taking place?
This year's Glaucoma 360 will occur from February 6 to February 8.
Who will be honored at the Gala?
Honorees include Dr. Sean Ianchulev and Dr. Michael Belkin, along with the Delta Gamma organization, recognized for their significant contributions to glaucoma research and advocacy.
What topics will be covered during the New Horizons Forum?
The New Horizons Forum will cover innovative therapies, education, and the latest advancements in glaucoma care, featuring discussions among industry leaders.
How does AI contribute to glaucoma care?
Artificial intelligence is reshaping glaucoma diagnosis and management, enabling healthcare providers to offer more accurate and timely treatments.
